Vivos Therapeutics (VVOS) to Release Earnings on Thursday

Vivos Therapeutics (NASDAQ:VVOS) will likely be posting its quarterly earnings results before the market opens on Thursday, March 27th. Analysts expect Vivos Therapeutics to post earnings of ($0.43) per share and revenue of $3.89 million for the quarter.

Vivos Therapeutics Trading Down 5.9 %

Shares of VVOS opened at $3.49 on Wednesday. The stock’s 50 day moving average is $3.93 and its two-hundred day moving average is $3.60. Vivos Therapeutics has a twelve month low of $1.91 and a twelve month high of $6.28. The firm has a market capitalization of $20.56 million, a PE ratio of -0.61 and a beta of 7.47.

Vivos Therapeutics Company Profile

Vivos Therapeutics, Inc, a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring.